Instil Bio Inc (TIL)

Oct 13, 2026

TIL S-8 & SEC Filings - Yahoo! Finance Canada

Oct 13, 2026

Oct 12, 2026

Instil Bio, Inc. (TIL) Stock Price History & Data - Traders Union

Oct 12, 2026

Oct 12, 2026

Instil Bio, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (TIL) - Traders Union

Oct 12, 2026

Sep 08, 2026

TIL Q2 2026 Earnings: Wider-than-Expected Loss Highlights Clinical-Stage Cost PressuresDebt Analysis Report - dars.gov.et

Sep 08, 2026

Sep 08, 2026

TIL Q2 2026 Earnings: Wider-than-Expected Loss Highlights Clinical-Stage Cost PressuresRevenue Growth Report - dars.gov.et

Sep 08, 2026

Sep 04, 2026

Press Release: Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Moomoo

Sep 04, 2026

Sep 04, 2026

(TIL) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Sep 04, 2026

Aug 16, 2026

TIL Should I Buy - Intellectia AI

Aug 16, 2026

Aug 14, 2026

Why (TIL) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Aug 14, 2026

Aug 13, 2026

Instil Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2026

Aug 13, 2026

Form 8K Instil Bio Inc For: 13 August By Investing.com - Investing.com Nigeria

Aug 13, 2026

Aug 13, 2026

Instil Bio Reports Second Quarter 2026 Financial Results - Intellectia AI

Aug 13, 2026

Aug 13, 2026

Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

Aug 13, 2026

Aug 13, 2026

Instil Bio Reports $4.3 Million Second-Quarter 2026 Net Loss - Quiver Quantitative

Aug 13, 2026

Aug 13, 2026

Form 8K Instil Bio Inc For: 13 August By Investing.com - Investing.com India

Aug 13, 2026

Aug 13, 2026

Form 8K Instil Bio Inc For: 13 August By Investing.com - Investing.com Canada

Aug 13, 2026

Aug 13, 2026

Instil Bio, Inc. 2026: Revenue ($4.35M), Net income ($4.3M), EPS ($0.63) — 10-Q Summary - TradingView

Aug 13, 2026

Aug 13, 2026

Instil Bio reports Q2 2026 net loss $4.3M, cash and marketable securities $69.9M - TradingView

Aug 13, 2026

Aug 13, 2026

Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Enidnews.com

Aug 13, 2026

Aug 13, 2026

Form 8K Instil Bio Inc For: 13 August By Investing.com - Investing.com UK

Aug 13, 2026

Aug 13, 2026

Instil Bio (TIL) slashes R&D spend and leans on Tarzana lease income in Q2 2026 - Stock Titan

Aug 13, 2026

Aug 13, 2026

Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - marketscreener.com

Aug 13, 2026

Aug 13, 2026

Instil Bio expects $69.9M cash to fund plan beyond 2027 - Stock Titan

Aug 13, 2026

Aug 13, 2026

Instil Bio (Nasdaq: TIL) trims Q2 2026 loss and extends cash runway - Stock Titan

Aug 13, 2026

Aug 13, 2026

Instil Bio (TIL) Dips 2.7% as Shares Hover Near Key SupportJurik MA - vinanet.vn

Aug 13, 2026

Aug 13, 2026

Instil Bio (TIL) Dips 2.7% as Shares Hover Near Key SupportDefined Outcome ETF - dars.gov.et

Aug 13, 2026

Aug 13, 2026

Instil Bio (TIL) Dips 2.7% as Shares Hover Near Key SupportWave Extension - dars.gov.et

Aug 13, 2026

Aug 12, 2026

TIL Q1 2026 Earnings: Wider-than-Expected Loss as Clinical Pipeline Execution Takes Center StageEarnings Volatility Report - vinanet.vn

Aug 12, 2026

Aug 12, 2026

TIL Q1 2026 Earnings: Wider-than-Expected Loss as Clinical Pipeline Execution Takes Center StageEarnings Cycle Outlook - careplusvn.com

Aug 12, 2026

Aug 11, 2026

Instil Bio (TIL) Edges Higher: Biotech Stock Holds Above Key SupportPut Dominated - vinanet.vn

Aug 11, 2026

Aug 07, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Instil Bio, Inc. (TIL) And Encourages Investors to Connect - The National Law Review

Aug 07, 2026

Aug 07, 2026

Instil Bio, Inc. expected to post a loss of 43 cents a shareEarnings Preview - TradingView

Aug 07, 2026

Aug 07, 2026

Instil Bio Inc (TIL) Stock News Today - TradingKey

Aug 07, 2026

Aug 05, 2026

Instil Bio Inc (TIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 05, 2026

Aug 04, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Aug 04, 2026

Aug 01, 2026

Instil Bio Q1 2026 Earnings: EPS Miss Reflects Continued Pre-Clinical-Stage InvestmentNew Analyst Coverage - careplusvn.com

Aug 01, 2026

Aug 01, 2026

Instil Bio Q1 2026 Earnings: EPS Miss Reflects Continued Pre-Clinical-Stage InvestmentFinancial Summary - vinanet.vn

Aug 01, 2026

Jul 31, 2026

TIL Q2'26 Earnings: revenue estimate is 0 USD - TradingView

Jul 31, 2026

Jul 29, 2026

Instil Bio (TIL) Edges Lower Near Key Support LevelsOvervalued Signals - vinanet.vn

Jul 29, 2026

Jul 28, 2026

Instil Bio Inc (TIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 28, 2026

Jul 27, 2026

TIL|Instil Bio Inc|Price:7.380|Chg%:-0.030 - TradingKey

Jul 27, 2026

Jul 27, 2026

Instil Bio Inc (TIL) Balance Sheet - TradingKey

Jul 27, 2026

Jul 27, 2026

Instil Bio Inc (TIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 27, 2026

Jul 27, 2026

Instil Bio Inc (TIL) Income Statement - TradingKey

Jul 27, 2026

Jul 27, 2026

Instil Bio Inc (TIL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026

Jul 27, 2026

TIL|Instil Bio Inc|Price:7.130|Chg%:-0.070 - TradingKey

Jul 27, 2026

Jul 27, 2026

Instil Bio Inc (TIL) Cash Flow - TradingKey

Jul 27, 2026

Jul 27, 2026

Instil Bio, Inc. Revenue Breakdown – NASDAQ:TIL - TradingView

Jul 27, 2026

Jul 27, 2026

TIL|Instil Bio Inc|Price:7.430|Chg%:+0.040 - TradingKey

Jul 27, 2026

Jul 26, 2026

Instil Bio Inc (TIL) Institutional Confidence - TradingKey

Jul 26, 2026